Overview Effect of Cytochrome P 450 3A4 Inhibition by Itraconazole on the Single Oral Dose Pharmacokinetics of Cilobradine Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Study to investigate the effect of cytochrome P 450 3A4 inhibition by itraconazole on the single dose pharmacokinetics of cilobradine Phase: Phase 1 Details Lead Sponsor: Boehringer IngelheimTreatments: HydroxyitraconazoleItraconazole